Cardiff Oncology Inc - Company Profile
Powered by 
All the sales intelligence you need on Cardiff Oncology Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Cardiff Oncology Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Cardiff Oncology Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Cardiff Oncology Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4146346A1 | Application | VERFAHREN ZUR ÜBERWACHUNG VON KRAS-MUTATIONEN | A61P35/00; C12Q1/6886; C12Q2600/106; C12Q2600/156 | March 15, 2023 |
| EP3946313A4 | Search Report | PLK1-INHIBITOREN UND PSA-SPIEGEL BEI PROSTATAKREBS | A61K31/519; A61K31/58; A61K45/06; A61P35/00 | December 07, 2022 |
| WO2022217060A1 | Application | CANCER TREATMENT USING PARP INHIBITORS AND PLK1 INHIBITORS | October 13, 2022 | |
| US20220184086A1 | Application | PLK1 INHIBITORS AND PSA LEVELS IN PROSTATE CANCER | A61K31/519; A61K31/58; A61P35/00 | June 16, 2022 |
| US20220143021A1 | Application | ONVANSERTIB FOR INHIBITING NON-ADRENERGIC CONTRACTION OF SMOOTH MUSCLE AND PROSTATE CELL PROLIFERATION | A61K31/517; A61K45/06; A61P13/08 | May 12, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer